Documentation in stability studies

Every batch of clinical trial material is not necessarily included in stability studies however, because so many factors that can affect stability (e.g., formulation, manufacturing, container-closure) change during product development, many if not most clinical trial materials are included in some form of stability study. The results of the stability studies and the rationale for not conducting stability studies should be documented and organized appropriately in anticipation of regulatory review during pre-approval inspections (PAIs). 

The existence of copper(I) isocyanide complexes is well documented, of course (90). Such complexes are basically straightforward, having stoichiometries and physical and chemical properties analogous to other copper(I) complexes. It would be somewhat surprising if the studies currently underway on the catalytic systems had not attempted to sketch in this relationship more precisely. No copper(O) isocyanide complexes are known, so such species if they exist here would be particularly interesting their stability is clearly low with respect to ligand dissociation, or they would have been isolated in these studies. 

Fate of plant viruses after a soil solarization treatment was almost completely ignored by researchers, as only one study documented a stabilizing effect of heat treatment on tobacco mosaic virus degradation in a sandy loam soil (Triolo and Materazzi 1992). 

The formal validation is often completed after the PAI, where three-batch process validation will be conducted in accordance with the protocol approved during the preapproval inspection. The primary objective of the formal process validation exercise is to establish process reproducibility and consistency. Such validation must be completed before entering the market. The formal validation studies continue through packaging and labeling operations (in whole or in part), so that machinability and stability of the finished product can be established and documented in the primary container-closure system. 

A very large volume of work on 1,2-diaminoethane and related complexes exists and their properties are well documented. There are several features of interest in recent studies.9-15,14680-11 The stability constants for the formation of Zn—en complexes in DMF have been... 

The (5)-tryptophan-derived oxazaborolidenes utilized in this aldol study have been previously examined by Corey as effective catalysts for enantioselective Diels-Alder cycloaddition reactions [6]. Corey has documented unique physical properties of the complex and has proposed that the electron-rich indole participates in stabilizing a donor-acceptor interaction with the metal-bound polarized aldehyde. More recently, Corey has formulated a model exemplified by 7 in which binding by the aldehyde to the metal is rigidified through the formation of a hydrogen-bond between the polarized formyl C-H and an oxyanionic ligand [7], The model illustrates the sophisticated design elements that can be incorporated into the preparation of transition-metal complexes that lead to exquisite control in aldehyde enantiofacial differentiation. 

Feeding of animals in general can enhance the omega-3 levels in lipids and is well documented. In contrast, few studies have documented the stability of the lipids in stored meats or in processed meat products. Additional researcher is needed to evaluate the sensory characteristics of stored meats and of processed meat products containing enhanced omega-3 lipids. 

Menger et al. synthesized a Ci4H29-attached copper(II) complex 3 that possessed a remarkable catalytic activity in the hydrolysis of diphenyl 4-nitrophenyl phosphate (DNP) and the nerve gas Soman (see Scheme 2) [21], When 3 was used in great excess (ca. 1.5 mM, which is more than the critical micelle concentration of 0.18 mM), the hydrolysis of DNP (0.04 mM) was more than 200 times faster than with an equivalent concentration of the nonmicellar homo-logue, the Cu2+-tetramethylethylenediamine complex 9, at 25°C and pH 6 (Scheme 4). The DNP half-life is calculated to be 17 sec with excess 1.5 mM 3 at 25°C and pH 6. The possible reasons for the rate acceleration with 3 were the enhanced electrophilicity of the micellized copper(II) ion or the acidity of the Cu2+-bound water and an intramolecular type of reaction due to the micellar formation. On the basis of the pH(6-8.3)-insensitive rates, Cu2+-OH species 3b (generated with pK3 < 6) was postulated to be an active catalytic species. In this study, the stability constants for 3 and 9 and the thermodynamic pvalue of the Cu2+-bound water for 3a —> 3b + H+ were not measured, probably because of complexity and/or instability of the metal compounds. Therefore, the question remains as to whether or not 3b is the only active species in the reaction solution. Despite the lack of a detailed reaction mechanism, 3 seems to be the best detoxifying reagent documented in the literature. 

All stability studies on clinical trial materials must be carried out in full accordance with cGMPs, even if a research department carries out the studies. All studies must be carried out by adequately trained personnel under adequate work conditions. The personnel must use properly qualified and calibrated stability chambers, instruments, reagents, and standards. They must follow validated analytical methods and approved written procedures, and they must properly document all work. There must be proper sample and data traceability, change control, and go on. 

Characterization of the vector batch used in non-clinical safety studies is also performed in compliance with GLPs. Care should be taken to ensure that adequate and appropriate processes are used to produce the batch(es) required, and the production process should be similar to that proposed for production of the vector for human clinical trials, or at least performed in such a way that adequate documentation of the production methods is available for comparative purposes. The GLP regulations state that the identity, purity, and composition of the vector batch (test article) used in a safety study must be known and documented. In addition, the stability of the vector preparation in the specific container used for the study must also be known prior to initiation of the study or acquired concomitantly with the study itself. These test article characterization experiments require that the researcher produce additional amounts of vector identical to the material used in... 

---